This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Jasper Therapeutics faces class action
Business class action

Jasper Therapeutics faces class action

Analysis based on 15 articles · First reported Sep 21, 2025 · Last updated Oct 07, 2025

Sentiment
-50
Attention
2
Articles
15
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Jasper Therapeutics could negatively impact its stock price and investor confidence due to allegations of false and misleading statements. Investors who purchased Jasper Therapeutics securities during the Class Period may be entitled to compensation.

Biotechnology Legal Services
Event Summary

Rosen Law Firm has filed a class action lawsuit against Jasper Therapeutics on behalf of investors who purchased its securities between November 30, 2023, and July 3, 2025. The lawsuit alleges that Jasper Therapeutics made false and misleading statements by failing to disclose inadequate controls and procedures for third-party manufacturers, which increased the risk of confounded study results and negatively impacted the regulatory and commercial prospects of its products, including briquilimab. This failure also allegedly increased the likelihood of disruptive cost-reduction measures, leading to an overstatement of Jasper Therapeutics' business and financial prospects. Investors are encouraged to join the lawsuit by the lead plaintiff deadline of November 18, 2025.

Entities Involved
stock
Jasper Therapeutics
Jasper Therapeutics is the defendant in a class action lawsuit alleging false and misleading statements regarding its manufacturing controls and product prospects, which could lead to significant financial damages and reputational harm.
Importance 100.0 Sentiment -70.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
Relationships
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.